Figure 4
From: Novel CO2-encapsulated Pluronic F127 hydrogel for the treatment of Achilles tendon injury

In vitro (A) daily and (B) accumulated release of bupivacaine from CO2-encapsulated hydrogel.
From: Novel CO2-encapsulated Pluronic F127 hydrogel for the treatment of Achilles tendon injury

In vitro (A) daily and (B) accumulated release of bupivacaine from CO2-encapsulated hydrogel.